Cargando…
Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
OBJECTIVE: To examine the efficacy and safety of dual blockade of the renin-angiotensin-aldosterone system (RAAS) among patients with type 2 diabetic kidney disease. DATA SOURCES: We searched the major literature repositories, including the Cochrane Central Register of Controlled Trials, MEDLINE and...
Autores principales: | Feng, Yan-Huan, Fu, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797548/ https://www.ncbi.nlm.nih.gov/pubmed/26712437 http://dx.doi.org/10.4103/0366-6999.172599 |
Ejemplares similares
-
Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020) -
Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
por: Lozano-Maneiro, Luz, et al.
Publicado: (2015) -
Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
por: Houston Miller, Nancy
Publicado: (2010) -
Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy
por: Ravid, Mordchai
Publicado: (2009) -
Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients
por: Vejakama, Phisitt, et al.
Publicado: (2017)